Radiofrequency and microwave hyperthermia in cancer treatment
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68407700%3A21460%2F21%3A00353134" target="_blank" >RIV/68407700:21460/21:00353134 - isvavai.cz</a>
Výsledek na webu
<a href="https://doi.org/10.1016/B978-0-12-820594-5.00007-1" target="_blank" >https://doi.org/10.1016/B978-0-12-820594-5.00007-1</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/B978-0-12-820594-5.00007-1" target="_blank" >10.1016/B978-0-12-820594-5.00007-1</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Radiofrequency and microwave hyperthermia in cancer treatment
Popis výsledku v původním jazyce
Hyperthermia therapy involves mild heating (40–44°C) that has been shown to be a potent enhancer of radiation and chemotherapy. Microwave (MW) and radiofrequency (RF) hyperthermia devices provide a variety of heating approaches that can treat most cancers regardless of their size and depth. This review introduces the physics of MW/RF hyperthermia, the current state-of-the-art systems for both local and regional heating, and recent advancements in hyperthermia treatment planning and guidance using real-time magnetic resonance imaging. The clinical evidence from clinical trials involving RF/MW hyperthermia as an adjuvant for radiation and chemotherapy is reviewed to show that adequate heating can be obtained with state-of-the-art systems. These studies strongly support the use of adjuvant hyperthermia as it significantly improves curative and palliative clinical outcomes. We anticipate that recent technology advances will improve the treatment delivery and reduce its complexity, as pivotal components for expanding the use of hyperthermia at medical and radiation oncology centers and enhancing cancer therapy.
Název v anglickém jazyce
Radiofrequency and microwave hyperthermia in cancer treatment
Popis výsledku anglicky
Hyperthermia therapy involves mild heating (40–44°C) that has been shown to be a potent enhancer of radiation and chemotherapy. Microwave (MW) and radiofrequency (RF) hyperthermia devices provide a variety of heating approaches that can treat most cancers regardless of their size and depth. This review introduces the physics of MW/RF hyperthermia, the current state-of-the-art systems for both local and regional heating, and recent advancements in hyperthermia treatment planning and guidance using real-time magnetic resonance imaging. The clinical evidence from clinical trials involving RF/MW hyperthermia as an adjuvant for radiation and chemotherapy is reviewed to show that adequate heating can be obtained with state-of-the-art systems. These studies strongly support the use of adjuvant hyperthermia as it significantly improves curative and palliative clinical outcomes. We anticipate that recent technology advances will improve the treatment delivery and reduce its complexity, as pivotal components for expanding the use of hyperthermia at medical and radiation oncology centers and enhancing cancer therapy.
Klasifikace
Druh
C - Kapitola v odborné knize
CEP obor
—
OECD FORD obor
20601 - Medical engineering
Návaznosti výsledku
Projekt
<a href="/cs/project/GA21-00579S" target="_blank" >GA21-00579S: Multifyzikální studie superpozice elektromagnetických vln v modelu lidské hlavy pro ověření proveditelnosti mikrovlnné hypertermie nádorů mozku</a><br>
Návaznosti
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Ostatní
Rok uplatnění
2021
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název knihy nebo sborníku
Principles and Technologies for Electromagnetic Energy Based Therapies
ISBN
978-0-12-820594-5
Počet stran výsledku
31
Strana od-do
281-311
Počet stran knihy
406
Název nakladatele
Academic Press Elsevier
Místo vydání
—
Kód UT WoS kapitoly
—